Citation Impact
Citing Papers
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Chagas disease
2010 Standout
Concordant Regulation of Gene Expression by Hypoxia and 2-Oxoglutarate-dependent Dioxygenase Inhibition
2006 StandoutNobel
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
Ventricular remodeling in heart failure and the effect of β-blockade
2004
Structure of a mammalian ryanodine receptor
2014 StandoutNatureNobel
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy
2001 StandoutNobel
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
2010 Standout
Cellular basis of ventricular remodeling after myocardial infarction
1991
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
1996 Standout
Analysis of Randomized Controlled Trials on the Effect of Magnitude of Heart Rate Reduction on Clinical Outcomes in Patients With Systolic Chronic Heart Failure Receiving Beta-Blockers
2008
Bone marrow cells regenerate infarcted myocardium
2001 StandoutNature
Spinal-cord injury
2002 Standout
Myocardial ischemia, reperfusion and free radical injury
1990
Regulation of collagen degradation in the rat myocardium after infarction
1995
Molecular basis of the VHL hereditary cancer syndrome
2002 StandoutNobel
Factors affecting sensitivity and specificity of a diagnostic test: the exercise thallium scintigram
1988
Severe head injury in the United Kingdom and Ireland
1996
Quantification of coronary artery calcium using ultrafast computed tomography
1990 Standout
Assessment of Left Atrial Appendage Structure and Function by Transesophageal Echocardiography
1998
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Traumatic brain injury
2000 Standout
Mechanisms of Actions of Inhaled Anesthetics
2003 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
CHARITY: Cha gas car diomyopathy bi soprolol int ervention study: a randomized double-blind placebo force-titration controlled study with Bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy [NCT00323973]
2006
The myocardial matrix and the development and progression of ventricular remodeling
2000
How oxygen makes its presence felt: Figure 1.
2002 StandoutNobel
Colorectal cancer
2019 Standout
Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision
2016
Direct extraction and estimation of collagenase(s) activity by zymography in microquantities of rat myocardium and uterus
1993
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
HIF hydroxylation and the mammalian oxygen-sensing pathway
2003 StandoutNobel
Novel Pharmacologic Strategies in the Treatment of Experimental Traumatic Brain Injury: 1998
1998
Contribution of Myeloperoxidase to Smoking-dependent Vascular Inflammation
2008
Pharmacology of carvedilol
2004
Hypoxia of the Renal Medulla — Its Implications for Disease
1995 Standout
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
Effect of captopril and enalapril on left ventricular geometry, function and collagen during healing after anterior and inferior myocardial infarction in a dog model
1995
Current Status of Neuroprotection Trials for Traumatic Brain Injury: Lessons from Animal Models and Clinical Studies
1999
Importance of epidemiology and biostatistics in deciding clinical strategies for using diagnostic tests: A simplified approach using examples from coronary artery disease
1989
The cellular basis of dilated cardiomyopathy in humans
1995
Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression.
1994
A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type 2 Diabetes
2010
Reactive oxygen species in cardiovascular disease
2011
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
2007
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial
2004 Standout
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 Standout
EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection
2016 StandoutNobel
A role for glucagon-like peptide-1 in the central regulation of feeding
1996 StandoutNature
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
Apoptosis in the Failing Human Heart
1997 Standout
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
Digital subtraction fluoroscopy: a new method of detecting coronary calcifications with improved sensitivity for the prediction of coronary disease.
1985
Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.
1991 Standout
PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle
2003
β-Blockers in Chronic Heart Failure
2003
Inhibition of Collagen Synthesis With Prolyl 4-Hydroxylase Inhibitor Improves Left Ventricular Function and Alters the Pattern of Left Ventricular Dilatation After Myocardial Infarction
2001
HIF hydroxylation and the mammalian oxygen-sensing pathway
2003 StandoutNobel
Overexpression of angiotensin AT 1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block
1997 StandoutNobel
Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor
2002 StandoutNobel
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
PROLINE HYDROXYLATION AND GENE EXPRESSION
2005 StandoutNobel
Effect of Nitrous Oxide on Excitatory and Inhibitory Synaptic Transmission in Hippocampal Cultures
1998
The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence.
1991
Mobilized bone marrow cells repair the infarcted heart, improving function and survival
2001 Standout
β-Adrenergic Receptor Blockade in Chronic Heart Failure
2000
Measurement of Fractional Flow Reserve to Assess the Functional Severity of Coronary-Artery Stenoses
1996 Standout
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Myocyte cellular hyperplasia and myocyte cellular hypertrophy contribute to chronic ventricular remodeling in coronary artery narrowing-induced cardiomyopathy in rats.
1994
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Functional connectivity in the resting brain: A network analysis of the default mode hypothesis
2002 Standout
Critical analysis of the application of bayes' theorem to sequential testing in the noninvasive diagnosis of coronary artery disease
1984
Cardiac cinefluoroscopy as an inexpensive aid in the diagnosis of coronary artery disease
1986
Brain Mechanisms of Propofol-Induced Loss of Consciousness in Humans: a Positron Emission Tomographic Study
1999
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats.
1990
Influence of β -Blockers on Mortality in Chronic Heart Failure
2000
Regulation of Fibrillar Collagen Gene Expression and Protein Accumulation in Volume-Overloaded Cardiac Hypertrophy
1997
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
2010 Standout
The Cellular Basis of Pacing-Induced Dilated Cardiomyopathy
1995
Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
1993
Works of Calvin Eng being referenced
Isoflurane compared with nitrous oxide anaesthesia for intraoperative monitoring of somatosensory-evoked potentials
1994
Ketamine Alters Calcium and Magnesium in Brain Tissue following Experimental Head Trauma in Rats
1993
Prognostic Implications of Normal (<0.10 ng/ml) and Borderline (0.10 to 1.49 ng/ml) Troponin Elevation Levels in Critically Ill Patients Without Acute Coronary Syndrome
2008
Usefulness of Baseline Plasma Myeloperoxidase Levels as an Independent Predictor of Myocardial Infarction at Two Years in Patients Presenting With Acute Coronary Syndrome
2007
Profound structural alterations of the extracellular collagen matrix in postischemic dysfunctional (“stunned”) but viable myocardium
1987
The effects of acutely increased ventricular cavity pressure on intrinsic myocardial connective tissue
1988
Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction
2006
Plasma Interleukin-10 Levels and Adverse Outcomes in Acute Coronary Syndrome
2011
Low Plasma RANTES Levels Are an Independent Predictor of Cardiac Mortality in Patients Referred for Coronary Angiography
2007
The Effect of Alfentanil on Cerebral Blood Flow Velocity and Intracranial Pressure during Isoflurane-Nitrous Oxide Anesthesia in Humans
1993
A nonflow basis for the vulnerability of the subendocardium
1987
Exendin-3 and -4 are insulin secretagogues
1992
The Influence of Propofol with and without Nitrous Oxide on Cerebral Blood Flow Velocity and CO2 Reactivity in Humans
1992
Bayesian comparison of cost-effectiveness of different clinical approaches to diagnose coronary artery disease
1984
Coronary collateral function during exercise.
1982
Mechanism of left atrial appendageal stunning after cardioversion: Electrical jolt or rhythm change? A transesophageal echocardiographic study
1995
Collagen loss in the stunned myocardium.
1992
Can exercise electrocardiography and thallium-201 myocardial imaging exclude the diagnosis of coronary artery disease?
1982
Prospective, Randomized Comparison of Effect of Long-Term Treatment With Metoprolol or Carvedilol on Symptoms, Exercise, Ejection Fraction, and Oxidative Stress in Heart Failure
1999
Practical diagnosis of coronary artery disease: A Bayes' theorem nomogram to correlate clinical data with noninvasive exercise tests
1984
Can noninvasive exercise test criteria identify patients with left main or 3-vessel coronary disease after a first myocardial infarction?
1983